Literature DB >> 9371610

The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells.

C Pallier1, A Greco, J Le Junter, A Saib, I Vassias, F Morinet.   

Abstract

Although parvoviruses are found throughout the animal kingdom, only the human pathogenic B19 virus has so far been shown to possess a limited host range, with erythroid progenitor cells as the main target cells supporting B19 propagation. The underlying mechanism of such erythroid tropism is still unexplained. Synthesis of the NS1 nonstructural protein occurs in permissive and nonpermissive cells, such as megakaryocytes, whereas synthesis of the VP1 and VP2 capsid proteins seems to be restricted to burst-forming units and CFU of erythroid cells. In nonpermissive cells, the NS1 protein is overexpressed and the NS1 RNAs are the predominant RNA species. However, the VP1 and VP2 proteins are not detectable, although the corresponding mRNAs are synthesized. Since all transcripts have part of the 5' untranslated region (5' UTR) in common but distinct 3' UTRs characterizing the nonstructural- and structural-protein mRNAs, we investigated, in transient transfection assays, the possible involvement of the 3' UTR of the capsid protein mRNAs in VP1 and VP2 protein synthesis in nonpermissive Cos cells. The results showed that (i) the 3' UTR of mRNAs coding for the capsid proteins repressed VP1 and VP2 protein synthesis, (ii) the 3' UTR did not affect nuclear export or mRNA stability, and (iii) mRNAs bearing the 3' UTR of the capsid protein mRNAs did not associate with ribosomes at all. Taken together, these results indicate that in nonpermissive cells, the 3' UTR of the capsid protein mRNAs represses capsid protein synthesis at the translational level by inhibiting ribosome loading.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371610      PMCID: PMC230254     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments.

Authors:  S F Cotmore; V C McKie; L J Anderson; C R Astell; P Tattersall
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

3.  Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Authors:  R O Shade; M C Blundell; S F Cotmore; P Tattersall; C R Astell
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

4.  Translational regulation of B19 parvovirus capsid protein production by multiple upstream AUG triplets.

Authors:  K Ozawa; J Ayub; N Young
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

5.  In vitro identification of a B19 parvovirus promoter.

Authors:  M C Blundell; C Beard; C R Astell
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

6.  The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells.

Authors:  K Ozawa; J Ayub; S Kajigaya; T Shimada; N Young
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Transient expression of B19 parvovirus gene products in COS-7 cells transfected with B19-SV40 hybrid vectors.

Authors:  C Beard; J St Amand; C R Astell
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

8.  The hepatitis B virus posttranscriptional regulatory element contains a highly stable RNA secondary structure.

Authors:  V Patzel; G Sczakiel
Journal:  Biochem Biophys Res Commun       Date:  1997-02-24       Impact factor: 3.575

9.  Novel transcription map for the B19 (human) pathogenic parvovirus.

Authors:  K Ozawa; J Ayub; Y S Hao; G Kurtzman; T Shimada; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

10.  Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures.

Authors:  K Ozawa; N Young
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

View more
  11 in total

1.  Possible involvement of miRNAs in tropism of Parvovirus B19.

Authors:  Azadeh Anbarlou; Mahshid AkhavanRahnama; Amir Atashi; Masoud Soleimani; Ehsan Arefian; Giorgio Gallinella
Journal:  Mol Biol Rep       Date:  2016-02-15       Impact factor: 2.316

2.  Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.

Authors:  Brian D Poole; Jing Zhou; Amy Grote; Adam Schiffenbauer; Stanley J Naides
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19.

Authors:  N Sol; J Le Junter; I Vassias; J M Freyssinier; A Thomas; A F Prigent; B B Rudkin; S Fichelson; F Morinet
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

4.  Codon optimization of human parvovirus B19 capsid genes greatly increases their expression in nonpermissive cells.

Authors:  Ning Zhi; Zhihong Wan; Xiaohong Liu; Susan Wong; Dong Joo Kim; Neal S Young; Sachiko Kajigaya
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

5.  Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.

Authors:  K A Weigel-Kelley; M C Yoder; A Srivastava
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

Review 6.  Advances in human B19 erythrovirus biology.

Authors:  Annabelle Servant-Delmas; Jean-Jacques Lefrère; Frédéric Morinet; Sylvie Pillet
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

7.  Antibody-mediated enhancement of parvovirus B19 uptake into endothelial cells mediated by a receptor for complement factor C1q.

Authors:  Kristina von Kietzell; Tanja Pozzuto; Regine Heilbronn; Tobias Grössl; Henry Fechner; Stefan Weger
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism.

Authors:  Remo Leisi; Nico Ruprecht; Christoph Kempf; Carlos Ros
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  Human parvovirus B19-associated hematopathy in HIV disease: need for clinicopathological revisit.

Authors:  Idris Abdullahi Nasir; Jessy Thomas Medugu
Journal:  J Biomed Res       Date:  2018-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.